of - 医索

找到约 1284 条结果

Can We Enhance the Benefit ofImmunotherapy in Non-Small CelLung Cancer

医客学院 - 会议报告集

BEAT-SC A randomized phase lll study ofbevacizumab or placebo in combination withatezolizumab and platinum-based chemotherapy inpatients with extensive-stage small cell lung cancer

医客学院 - 会议报告集

Amivantamab plus lazertinib vs osimertinib infirst-line EGFR-mutant advanced non-small cell lungcancer(NSCLC)with biomarkers of high-risk diseaseA secondary analysis from the phase 3 MARIPOSA study

医客学院 - 会议报告集

Adjuvant icotinib of 12 months or 6 months versus observationfollowing adjuvant chemotherapy for resected EGFR-mutatedstage ll-lllA non-small-cell lung cancer (ICTAN, GASTO1002) arandomized phase 3 trial

医客学院 - 会议报告集

A Multinational Pivotal Study of Sunvozertinib inPlatinum Pre-treated Non-Small Cell Lung Cancerwith EGFR Exon 20 Insertion MutationsPrimary Analysis of WU-KONG1 Study

医客学院 - 会议报告集

Primary Endpoint Analysis of the ORCHESTRA TRIAL

医客学院 - 会议报告集

Phase l trial of hypoxia-responsive CEA CAR-T celltherapy in patients with heavily pretreated solid tumorvia intraperitoneal or intravenous transfusion

医客学院 - 会议报告集

Overall survival (oS) of phase 3 CodeBreak 300 study ofsotorasib plus panitumumab (soto pani) versus investigator'schoice of therapy for KRAS G12c-mutated metastatic colorectacancer (mCRc)

医客学院 - 会议报告集

Neoadjuvant treatment of lBl310 (anti-CTLA-4 antibody) plus sintilimab(anti-PD.1 antibody) in patients with microsatellite instabilityhighmismatchrepair-deficient colon cancer Results from a randomiz

医客学院 - 会议报告集

MOUNTAINEER FINAL RESULTS OF APHASE 2 STUDY OF TUCATINIB ANDTRASTUZUMAB FOR HER2-POSITIVEMETASTATIC CRC

医客学院 - 会议报告集

今日实时热搜